Vaccine. 2003 Jun 20;21(21-22):2830-6.

Epidermal powder immunization of mice and monkeys with an influenza vaccine.

Chen D, Endres R, Maa YF, Kensil CR, Whitaker-Dowling P, Trichel A, Youngner JS, Payne LG.

Source

PowderJect Vaccines, Inc., 585 Science Drive, Madison, WI 53711, USA. dexiang_chen@powderject.com

Abstract

Epidermal powder immunization (EPI) with an influenza vaccine and an adjuvant such as QS-21, LTR72, or cholera toxin elicited augmented serum and mucosal antibody responses in mice. Rhesus macaques, which have an immune system and skin structure similar to humans, were used to further evaluate the immunogenicity of the influenza vaccine following EPI. EPI of rhesus macaques with an influenza vaccine and QS-21 adjuvant elicited significantly higher serum hemagglutination inhibition (HI) titers than antigen alone administered by EPI or by intramuscular (IM) injection using a needle and syringe. In the absence of QS-21, EPI and IM injection elicited comparable HI titers in the monkeys. This study suggests that EPI is a promising technique for administering human vaccine and that QS-21 augments the immunogenicity of co-administered influenza vaccine.

PMID:: 12798624; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Related citations

Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity. [Virus Res. 2004]
Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity.
Chen D, Burger M, Chu Q, Endres R, Zuleger C, Dean H, Payne LG. Virus Res. 2004 Jul; 103(1-2):147-53.
Epidermal powder immunization using non-toxic bacterial enterotoxin adjuvants with influenza vaccine augments protective immunity. [Vaccine. 2002]
Epidermal powder immunization using non-toxic bacterial enterotoxin adjuvants with influenza vaccine augments protective immunity.
Chen D, Endres RL, Erickson CA, Maa YF, Payne LG. Vaccine. 2002 Jun 21; 20(21-22):2671-9.
Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization. [J Virol. 2001]
Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization.
Chen D, Periwal SB, Larrivee K, Zuleger C, Erickson CA, Endres RL, Payne LG. J Virol. 2001 Sep; 75(17):7956-65.
Review Development of an adjuvant to enhance the immune response to influenza vaccine in the elderly. [Biologicals. 1997]
Review Development of an adjuvant to enhance the immune response to influenza vaccine in the elderly.
Martin JT. Biologicals. 1997 Jun; 25(2):209-13.
Review Needle-free influenza vaccination. [Lancet Infect Dis. 2010]
Review Needle-free influenza vaccination.
Amorij JP, Hinrichs WLj, Frijlink HW, Wilschut JC, Huckriede A. Lancet Infect Dis. 2010 Oct; 10(10):699-711.

See reviews... See all...

Cited by 2 PubMed Central articles

Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity. [Clin Vaccine Immunol. 2011]
Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.
Weldon WC, Martin MP, Zarnitsyn V, Wang B, Koutsonanos D, Skountzou I, Prausnitz MR, Compans RW. Clin Vaccine Immunol. 2011 Apr; 18(4):647-54. Epub 2011 Feb 2.
Review Development of stable influenza vaccine powder formulations: challenges and possibilities. [Pharm Res. 2008]
Review Development of stable influenza vaccine powder formulations: challenges and possibilities.
Amorij JP, Huckriede A, Wilschut J, Frijlink HW, Hinrichs WL. Pharm Res. 2008 Jun; 25(6):1256-73.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Epidermal powder immunization of mice and monkeys with an influenza vaccine.
Epidermal powder immunization of mice and monkeys with an influenza vaccine.
Vaccine. 2003 Jun 20 ;21(21-22):2830-6.

PubMed
Genotoxic stress induces coordinately regulated alternative splicing of the p53 ...
Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4.
Cancer Res. 2006 Oct 1 ;66(19):9502-8.

PubMed
Green tea reduces LDL oxidability and improves vascular function.
Green tea reduces LDL oxidability and improves vascular function.
J Am Coll Nutr. 2008 Apr ;27(2):209-13.

PubMed
Amblyopia.
Amblyopia.
Lancet. 2006 Apr 22 ;367(9519):1343-51.

PubMed
CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct ...
CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation.
Hepatology. 2008 Feb ;47(2):396-406.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Epidermal powder immunization of mice and monkeys with an influenza vaccine.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Related citations

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information